908 Devices Inc (MASS)
5.62
+0.06
(+1.08%)
USD |
NASDAQ |
Apr 24, 16:00
5.605
-0.02
(-0.27%)
After-Hours: 20:00
908 Devices Cash from Financing (TTM): -15.94M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -15.94M |
| September 30, 2023 | -15.62M |
| June 30, 2023 | -15.20M |
| March 31, 2023 | -14.33M |
| December 31, 2022 | 1.179M |
| September 30, 2022 | 95.30M |
| June 30, 2022 | 95.61M |
| Date | Value |
|---|---|
| March 31, 2022 | 95.42M |
| December 31, 2021 | 94.72M |
| September 30, 2021 | 137.38M |
| June 30, 2021 | 136.90M |
| March 31, 2021 | 136.62M |
| December 31, 2020 | 137.19M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-15.94M
Minimum
Dec 2023
137.38M
Maximum
Sep 2021
66.86M
Average
95.30M
Median
Sep 2022
Cash from Financing (TTM) Benchmarks
| Perspective Therapeutics Inc | 0.785M |
| Retractable Technologies Inc | 0.9416M |
| Xtant Medical Holdings Inc | 19.69M |
| Asensus Surgical Inc | 9.626M |
| Catheter Precision Inc | 8.386M |